Study Stopped
recruitment difficulties
Treatment of Subclinical Hyperthyroidism
Place de l'Iode RadioActif Dans l'HyperThyroïdiE Sub-clinique (PIRHATES)/ Evaluation of the Interest of Subclinical Hyperthyroidism Treatment
1 other identifier
observational
145
1 country
21
Brief Summary
Objective: To determine if the treatment of subclinical hyperthyroidism will reduce the rate of atrial fibrillation, the main complication of this condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2005
Longer than P75 for all trials
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 21, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedSeptember 29, 2020
August 1, 2019
14.3 years
September 13, 2005
September 25, 2020
Conditions
Keywords
Eligibility Criteria
patients referred to tertiary hospitals for advice on thyroïd disease
You may qualify if:
- Men and women aged 50 and greater
- Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels
You may not qualify if:
- Iodide overload
- Non sinusal heart rhythm
- Severe heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (21)
Patrick Roger
Bordeaux, France
Philippe Thiéblot
Clermont-Ferrand, France
Jean-Marcel Brun
Dijon, France
Jean-Louis Wemeau
Lille, France
Marie-Pierre Teissier
Limoges, France
Jacques Orgiazzi
Lyon, France
Bernard Conte-Delvox
Marseille, France
CH de Montbrison
Montbrison, 42605, France
Jacques Bringer
Montpellier, France
Marc Klein
Nancy, France
Michel Rodier
Nîmes, France
Laurence Leenhardt
Paris, France
Richard Marechaud
Poitiers, France
Brigitte Delemer
Reims, France
Claire Schvartz
Reims, France
Jean-Marc Kuhn
Rouen, France
Bruno Estour
Saint-Etienne, France
Centre Paul Strauss
Strasbourg, 67000, France
Hopitaux Universitaires de Strasbourg
Strasbourg, France
Philippe Caron
Toulouse, France
Pierre Lecomte
Tours, France
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bernard Goichot, MD
Hopitaux Universitaires de Strasbourg
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
August 1, 2005
Primary Completion
November 1, 2019
Study Completion
January 1, 2020
Last Updated
September 29, 2020
Record last verified: 2019-08